Kim, Doyeon published the artcileIdentification and characterization of potent, selective and metabolically stable IKKβ inhibitor, Recommanded Product: 4-(4-Chlorophenoxy)benzaldehyde, the main research area is rhodanine derivative preparation IKKbeta inhibitor structure activity; Allosteric inhibitor; IKKβ inhibitor; NF-κB; Reumatoid arthritis.
The authors have previously reported the identification of a rhodanine compound (I) with well-balanced inhibitory activity against IKKβ and collagen-induced TNFα activated cells. However, the authors need more optimized compounds because of its instability over plasma and microsome. As part of a program directed toward the optimization of IKKβ inhibitor, the authors modified a substituent of parent compound to a series of functional groups. Among substituted compounds, fluorine substituent (II) on the para position of Ph ring restored the stability toward plasma and microsome while retaining inhibitory potency and selectivity against IKKβ over other kinases. Also, the authors have demonstrated that compound (II) is an ATP non-competitive inhibitor and safe enough to apply to animal experiment from an acute toxicity test.
Bioorganic & Medicinal Chemistry Letters published new progress about Acute toxicity. 61343-99-5 belongs to class chlorides-buliding-blocks, name is 4-(4-Chlorophenoxy)benzaldehyde, and the molecular formula is C13H9ClO2, Recommanded Product: 4-(4-Chlorophenoxy)benzaldehyde.
Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics